Zika’s impact on male reproductive organs focus of new grant
Saguna Verma leads a research team that has discovered how the virus can hide in men's bodies long after they are infected.
Nearly $6.3M grant to expand promising Ebola vaccine research awarded to UH researcher
Axel Lehrer will test whether the Ebola vaccine formula he has developed will protect against two additional viruses in the same family.
ARCS Honolulu Scientist of the Year speaks on hantaviruses
Richard Yanagihara, an expert in emerging diseases, will discuss Hantaviruses: A Personal Journey of Discovery and New Beginnings at a free talk on September 14.
UH expands vaccine research through NIH grant to minority students
Liana Medina received a grant of nearly $112,000 to work with a potential vaccine for viruses related to Ebola.
Zika virus-infected mothers delivered babies with microcephaly as early as 2009
UH scientists’ finding adds to evidence linking the virus and severe fetal abnormalities.
Mukesh Kumar receives funding to find effective treatment for brain inflammation
The grant will support Kumar’s research on flavivirus infections—the leading cause to inflammation of the brain—tied to the West Nile, Japanese encephalitis, Zika and Dengue viruses.
Potential new Ebola vaccine has heat-stable formulation
JABSOM's Axel Lehrer shares preliminary test results for a promising Ebola vaccine being developed to retain effectiveness without refrigeration.
Malaria researcher wins Mānoa’s first Three-Minute Thesis competition
UH Mānoa graduate students representing 30 different majors and programs competed in the inaugural Three-Minute Thesis competition.
Heat stable Ebola vaccine goal of UH’s newest partner
Soligenix joins JABSOM ebola vaccine development project to develop a heat stable Ebola vaccine.
Ebola vaccine focus of UH and Hawaiʻi Biotech partnership
Hawaii Biotech to serve as commercial partner for UH Mānoa program
